WASHINGTON, Sept 29 (Reuters) - Firefly Aerospace (FLY.O), opens new tab on Monday said the core booster for its centerpiece Alpha rocket was destroyed during a ground test in Texas, weeks before that ...

The winners of this year's Sony Alpha Awards from Australia and New Zealand are truly captivating: from evocative frames of the natural world to dramatic and intimate human stories. For 2025, the ...

OpenAI is internally testing a new version of its AI agent, which uses a special version of GPT-5 dubbed "GPT-Alpha." Earlier today, OpenAI accidentally pushed an unreleased feature to everyone. As ...

An image from Firefly’s Sept. 22 earnings call presentation showed the next two Alpha rockets being prepared for launches before the end of this year. Credit: Firefly Aerospace WASHINGTON — Firefly ...

Gen Alpha is the generation born between 2010 and 2024. Nowadays, most slang terms are popularized by social media, many of which are pulled from AAVE or meme culture. Did you feel this article's ...

The U.S. Federal Aviation Administration (FAA) has cleared Firefly Aerospace to resume launches of its Alpha rocket. The approval follows a months-long review of the failed "Message in a Booster" ...

Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman. Imagine suddenly becoming allergic to a hamburger—or a steak or bacon or even certain cosmetics and medications. It’s ...

As an Amazon Associate, we earn from qualifying purchases. TweakTown may also earn commissions from other affiliate partners at no extra cost to you. UPDATE: There was a little communication issue ...

The term "alpha male" was coined in 1970 to describe wolves. But what does science think about the term now? When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

Connoisseur Media has completed its acquisition of Alpha Media following FCC approval on August 13, placing it among the top ten largest US radio broadcast companies by both station count and revenue.

Novartis is taking another shot at alpha-synuclein as a target for treating Parkinson’s disease via a $200 million upfront licensing deal with Arrowhead Pharmaceuticals. The Swiss pharma plans to use ...